药用大麻:目前的使用是否在临床上是合理的?
1West Moreton Mental Health Service, Brisbane, Queensland, Australia.
Internal medicine journal
|June 4, 2025
概括
药用大麻 (MC) 广泛用于慢性非癌症疼痛 (CNCP),但其有效性和安全性的证据有限且不一致. 医疗保健专业人员应向患者告知这些限制和潜在的危害.
科学领域:
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
- 公共卫生 公共卫生
背景情况:
- 药用大麻 (MC) 越来越多地被推销为慢性非癌症疼痛 (CNCP) 的天然治疗方法.
- 每月有超过100万澳大利亚人被处方MC,有800多种产品可供选择,但只有两种是TGA批准的.
- 这凸显了感知到的好处和监管机构的批准之间的差距.
研究的目的:
- 评估MC在治疗CNCP时的疗效和安全性的证据.
- 为医疗保健专业人员和患者提供有关当前MC研究局限性的信息.
- 解决行业推广与科学证据之间的差异.
主要方法:
- 对CNCP的MC现有文献进行系统审查.
- 分析证据的质量和在多次审查中的一致性.
- 检查澳大利亚的监管批准和产品可用性.
主要成果:
- 在CNCP中MC疗效的证据不一致,质量低,除了神经病痛.
- 没有可靠地确定受益于MC的特定患者表型.
- 报告不足的副作用包括认知障碍,镇静和精神病,特别是在老年人中.
结论:
- 目前的证据不支持对CNCP的MC的广泛或一线使用.
- 医疗保健专业人员必须向患者提供有效性和安全性数据的重大限制的建议.
- 鉴于证据缺陷,抵制行业对增加MC访问的压力至关重要.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
676
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
676
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
495
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
495
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
439
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
439
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
792
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
792
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Drug Control Governance: Regulatory Bodies and Their Impact
497
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
497


